Discovery of primary prostate cancer biomarkers using cross cancer learning
Abstract Prostate cancer (PCa), the second leading cause of cancer death in American men, is a relatively slow-growing malignancy with multiple early treatment options. Yet, a significant number of low-risk PCa patients are over-diagnosed and over-treated with significant and long-term quality of li...
Guardado en:
Autores principales: | Kaiyue Zhou, Suzan Arslanturk, Douglas B. Craig, Elisabeth Heath, Sorin Draghici |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce495cea89524f4a9f69c416fc8a182a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases
por: Jordy J. Hsiao, et al.
Publicado: (2021) -
Integrative epigenetic taxonomy of primary prostate cancer
por: Suzan Stelloo, et al.
Publicado: (2018) -
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
por: Shiqin Liu, et al.
Publicado: (2021) -
Biomarkers for Treatment Response in Advanced Prostate Cancer
por: Samia Asif, et al.
Publicado: (2021) -
Biomarkers for Prostate Cancer Diagnosis from Genetic Perspectives
por: Fatemeh Khatami, et al.
Publicado: (2020)